GE HealthCare has announced Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalised and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT was unveiled at ESTRO 2024 Congress in Glasgow, along with an updated and Artificial Intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) Planner.
One of the biggest challenges of oncology care is the complexity of the disease – both in the many varieties of cancer, and the disparate ways it can present in each individual patient – requiring diligence and personalisation in diagnosis and treatment. Additionally, treatment often requires the expertise of multiple disciplines and experts related to specific organs and systems in the body, resulting in potential delays to diagnosis and timely treatment. According to research published by the British Medical Journal, the mortality risk increases 6-13% for every month a diagnosis is delayed, therefore, it is critical to streamline the complex oncology care pathway and reduce the time from diagnosis to treatment, ultimately leading to improved patient outcomes.
Dr Taha Kass-Hout, Chief Technology and Science Officer of GE HealthCare, said: “Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumour targeting while aiming to protect nearby healthy tissue. By integrating these capabilities into our systems, we create a precise, more connected and efficient care environment that accelerates the delivery of personalised care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”